Carson Wealth (CWM LLC)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-387
Closed -$95K 4383
2022
Q3
$95K Buy
387
+102
+36% +$27.5K ﹤0.01% 1360
2022
Q2
$71K Buy
285
+66
+30% +$17.8K ﹤0.01% 1460
2022
Q1
$73K Buy
219
+139
+174% +$42.8K ﹤0.01% 1454
2021
Q4
$29K Buy
+80
New +$27K ﹤0.01% 1800
2021
Q2
$5K Hold
16
﹤0.01% 2395
2021
Q1
$5K Hold
16
﹤0.01% 2395
2020
Q4
$5K Hold
16
﹤0.01% 2395
2020
Q3
$5K Hold
16
﹤0.01% 2394
2020
Q2
$5K Hold
16
﹤0.01% 2390
2020
Q1
$5K Hold
16
﹤0.01% 2390
2019
Q4
$5K Hold
16
﹤0.01% 2390
2019
Q3
$5K Hold
16
﹤0.01% 2390
2019
Q2
$5K Hold
16
﹤0.01% 2390
2019
Q1
$5K Sell
16
-71
-82% -$23.6K ﹤0.01% 2389
2018
Q4
$28K Buy
87
+17
+24% +$5.91K ﹤0.01% 1041
2018
Q3
$31K Hold
70
﹤0.01% 856
2018
Q2
$29K Buy
70
+25
+56% +$9.06K ﹤0.01% 764
2018
Q1
$13K Hold
45
﹤0.01% 803
2017
Q4
$8K Hold
45
﹤0.01% 954
2017
Q3
$8K Buy
+45
New +$6.8K ﹤0.01% 964

Other funds holding ABMD

Carson Wealth (CWM LLC)'s ABMD Position: Q4 2022 in Review

Carson Wealth (CWM LLC) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 387 shares — an estimated $95K sold.

Carson Wealth (CWM LLC) first reported a position in ABMD in Q3 2017 and held it in 20 quarters. The position peaked at $95K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Carson Wealth (CWM LLC) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 387 Abiomed Inc shares in Q4 2022, an estimated $95K.
  • Carson Wealth (CWM LLC) first reported a position in Abiomed Inc in Q3 2017 and held it in 20 quarters.
  • Carson Wealth (CWM LLC)'s Abiomed Inc position peaked at $95K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2022, filed 1 Feb 2023.